Needham & Company LLC Upgrades ICU Medical (NASDAQ:ICUI) to Buy

ICU Medical (NASDAQ:ICUI) was upgraded by equities research analysts at Needham & Company LLC from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday, Marketbeat.com reports. The brokerage presently has a $165.00 price target on the medical instruments supplier’s stock. Needham & Company LLC’s price target would indicate a potential upside of 22.25% from the stock’s current price.

ICUI has been the topic of several other reports. Piper Sandler decreased their target price on shares of ICU Medical from $178.00 to $163.00 and set an “overweight” rating on the stock in a report on Friday, April 17th. Wall Street Zen raised shares of ICU Medical from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Jefferies Financial Group upgraded ICU Medical to a “strong-buy” rating in a report on Thursday, May 7th. KeyCorp lowered their price objective on ICU Medical from $180.00 to $164.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Finally, Weiss Ratings raised ICU Medical from a “sell (d)” rating to a “sell (d+)” rating in a research note on Monday, May 11th. Two investment analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of $168.00.

ICU Medical Price Performance

ICUI stock opened at $134.97 on Wednesday. ICU Medical has a 1 year low of $107.00 and a 1 year high of $160.29. The firm has a market capitalization of $3.37 billion, a PE ratio of 72.96, a price-to-earnings-growth ratio of 1.86 and a beta of 0.74. The business has a 50 day simple moving average of $125.64 and a 200-day simple moving average of $138.80. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.34 and a quick ratio of 1.17.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $1.97 EPS for the quarter, topping the consensus estimate of $1.78 by $0.19. ICU Medical had a return on equity of 7.50% and a net margin of 2.15%.The business had revenue of $525.77 million for the quarter, compared to analyst estimates of $520.65 million. During the same quarter in the previous year, the firm earned $1.72 EPS. The company’s quarterly revenue was down 12.3% compared to the same quarter last year. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. Equities research analysts anticipate that ICU Medical will post 6.5 earnings per share for the current fiscal year.

Insider Buying and Selling at ICU Medical

In other news, VP Virginia Ruth Sanzone sold 2,447 shares of the business’s stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $124.08, for a total value of $303,623.76. Following the completion of the sale, the vice president directly owned 19,460 shares of the company’s stock, valued at approximately $2,414,596.80. The trade was a 11.17% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director David C. Greenberg sold 2,424 shares of the company’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $122.91, for a total transaction of $297,933.84. Following the completion of the sale, the director owned 7,960 shares of the company’s stock, valued at approximately $978,363.60. This trade represents a 23.34% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 2.10% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the stock. Maryland State Retirement & Pension System raised its holdings in ICU Medical by 2.0% during the fourth quarter. Maryland State Retirement & Pension System now owns 3,619 shares of the medical instruments supplier’s stock worth $516,000 after purchasing an additional 70 shares in the last quarter. California Public Employees Retirement System raised its position in ICU Medical by 0.3% during the first quarter. California Public Employees Retirement System now owns 30,461 shares of the medical instruments supplier’s stock worth $3,934,000 after acquiring an additional 90 shares during the last quarter. Arizona State Retirement System boosted its stake in shares of ICU Medical by 1.3% during the third quarter. Arizona State Retirement System now owns 6,903 shares of the medical instruments supplier’s stock valued at $828,000 after acquiring an additional 91 shares during the last quarter. Oregon Public Employees Retirement Fund boosted its stake in shares of ICU Medical by 1.8% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 5,631 shares of the medical instruments supplier’s stock worth $803,000 after purchasing an additional 100 shares during the last quarter. Finally, Smartleaf Asset Management LLC lifted its stake in shares of ICU Medical by 11.6% during the 2nd quarter. Smartleaf Asset Management LLC now owns 969 shares of the medical instruments supplier’s stock worth $128,000 after purchasing an additional 101 shares during the period. Institutional investors and hedge funds own 96.10% of the company’s stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.